Your browser doesn't support javascript.
loading
The AF4-MLL fusion transiently augments multilineage hematopoietic engraftment but is not sufficient to initiate leukemia in cord blood CD34+ cells.
Prieto, Cristina; Marschalek, Rolf; Kühn, Alessa; Bursen, Adelheid; Bueno, Clara; Menéndez, Pablo.
Affiliation
  • Prieto C; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Barcelona, Spain.
  • Marschalek R; Institute of Pharmaceutical Biology/DCAL, Goethe-University, Frankfurt, Germany.
  • Kühn A; Institute of Pharmaceutical Biology/DCAL, Goethe-University, Frankfurt, Germany.
  • Bursen A; Institute of Pharmaceutical Biology/DCAL, Goethe-University, Frankfurt, Germany.
  • Bueno C; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Barcelona, Spain.
  • Menéndez P; Centro de Investigación Biomédica en Red de Cancer (CIBERONC), Barcelona, Spain.
Oncotarget ; 8(47): 81936-81941, 2017 Oct 10.
Article in En | MEDLINE | ID: mdl-29137234
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Oncotarget Year: 2017 Type: Article Affiliation country: Spain
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Oncotarget Year: 2017 Type: Article Affiliation country: Spain